Emerging Antibiotic Resistance: Epidemiology and New Mechanisms

Dear Colleagues,

The emergence of pathogenic bacteria, which cannot be effectively treated with current drugs, has been prioritized by the WHO as one of humanity's top ten global public health threats. Fighting this threat is a priority that requires a global approach across multiple sectors beyond healthcare, including the food supply chain and the environment. Antibiotic-resistant infections are linked to significant morbidity and mortality, and in 2019, they were estimated to contribute to 4.95 million deaths worldwide. Moreover, according to some projections, infections due to antimicrobial-resistant pathogens will be responsible for more deaths than cancer or diabetes in a matter of decades. As COVID-19 rages on, the pandemic of antimicrobial resistance continues in the shadows. Understanding antimicrobial resistance is crucial in developing new antimicrobial drugs to tackle drug-resistant bacteria.

Thus, this Special Issue aims to encourage submissions on the novel mechanisms and evolution of antimicrobial resistance, the epidemiology and surveillance of resistance in the clinical setting, clinical applications of current and novel antimicrobials, and strategies to prevent the emergence and dissemination of resistance, especially from regions of the world where epidemiological data are scarce. 

We look forward to receiving your manuscripts.

Dr. Murat Akova
Dr. Meliha Çaǧla Sönmezer
Dr. Taha Koray Sahin
Dr. Enes Erul
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.